| Condensed Consolidated Balance Sheet Components |
Condensed Consolidated Balance Sheet Components Property and Equipment, Net Property and equipment, net, consisted of the following (in thousands): | | | | | | | | | | | | | August 31,
2024 | | November 30,
2023 | | Laboratory equipment | $ | 37,840 | | | $ | 32,239 | | | Leasehold improvements | 3,274 | | | 3,238 | | | Computer equipment | 941 | | | 938 | | | Furniture and fixtures | 1,077 | | | 652 | | | Software | 5,376 | | | 5,403 | | | Software in progress | 663 | | | 587 | | | Total property and equipment, gross | 49,171 | | | 43,057 | | | Less: Accumulated depreciation and amortization | (32,102) | | | (26,249) | | | Total property and equipment, net | $ | 17,069 | | | $ | 16,808 | |
Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): | | | | | | | | | | | | | August 31,
2024 | | November 30,
2023 | | Accrued compensation | $ | 11,705 | | | $ | 15,303 | | | Accrued clinical, contract research and lab supplies | 12,719 | | | 7,131 | | | Accrued professional services | 1,836 | | | 1,755 | | | Accrued taxes | 906 | | | 30 | | | Other | 662 | | | 751 | | | Total accrued expenses and other current liabilities | $ | 27,828 | | | $ | 24,970 | |
|